Nxera Pharma Co., Ltd. JSS.F Stock
Nxera Pharma Co., Ltd. Price Chart
Nxera Pharma Co., Ltd. JSS.F Financial and Trading Overview
| Nxera Pharma Co., Ltd. stock price | 8.5 EUR |
| Previous Close | 10.4 EUR |
| Open | 10.6 EUR |
| Bid | 10.6 EUR x 0 |
| Ask | 11.1 EUR x 0 |
| Day's Range | 10.6 - 10.6 EUR |
| 52 Week Range | 8.9 - 20.6 EUR |
| Volume | 400 EUR |
| Avg. Volume | 22 EUR |
| Market Cap | 889.94M EUR |
| Beta (5Y Monthly) | 0.855791 |
| PE Ratio (TTM) | 75.71429 |
| EPS (TTM) | -0.63 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
JSS.F Valuation Measures
| Enterprise Value | -34605699072 EUR |
| Trailing P/E | 75.71429 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.058326326 |
| Price/Book (mrq) | 0.013928163 |
| Enterprise Value/Revenue | -2.268 |
| Enterprise Value/EBITDA | -9.033 |
Trading Information
Nxera Pharma Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.855791 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 20.6 EUR |
| 52 Week Low | 8.9 EUR |
| 50-Day Moving Average | 12.48 EUR |
| 200-Day Moving Average | 15.13 EUR |
JSS.F Share Statistics
| Avg. Volume (3 month) | 22 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 82.34M |
| Float | 65.58M |
| Short Ratio | N/A |
| % Held by Insiders | 10.26% |
| % Held by Institutions | 42.49% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | June 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 12.18% |
| Operating Margin (ttm) | 16.04% |
| Gross Margin | 95.93% |
| EBITDA Margin | 25.10% |
Management Effectiveness
| Return on Assets (ttm) | 1.56% |
| Return on Equity (ttm) | 3.12% |
Income Statement
| Revenue (ttm) | 15.26B EUR |
| Revenue Per Share (ttm) | 186.13 EUR |
| Quarterly Revenue Growth (yoy) | -10.10% |
| Gross Profit (ttm) | 14.64B EUR |
| EBITDA | 3.83B EUR |
| Net Income Avi to Common (ttm) | 1.86B EUR |
| Diluted EPS (ttm) | 0.14 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 65.91B EUR |
| Total Cash Per Share (mrq) | 800.52 EUR |
| Total Debt (mrq) | 30.45B EUR |
| Total Debt/Equity (mrq) | 48.59 EUR |
| Current Ratio (mrq) | 15.351 |
| Book Value Per Share (mrq) | 761.048 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 10.15B EUR |
| Levered Free Cash Flow (ttm) | 1.63B EUR |
Profile of Nxera Pharma Co., Ltd.
| Country | Germany |
| State | N/A |
| City | Tokyo |
| Address | PMO Hanzomon |
| ZIP | 102-0083 |
| Phone | 81 3 5210 3290 |
| Website | https://soseiheptares.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 211 |
Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of GPR35 agonist, for inflammatory bowel disease/GI disorders, which is in preclinical stage; HTL0016878 for Schizophrenia and other neuropsychiatric disorders; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; and PF-07258669 for anorexia. Sosei Group Corporation has a strategic collaboration with AbbVie, Biohaven, Genentech, GSK, Takeda, Pfizer, Neurocrine Biosciences, Novartis, Verily, AstraZeneca, and Takeda. The company was incorporated in 1990 and is headquartered in Tokyo, Japan.
Q&A For Nxera Pharma Co., Ltd. Stock
What is a current JSS.F stock price?
Nxera Pharma Co., Ltd. JSS.F stock price today per share is 8.5 EUR.
How to purchase Nxera Pharma Co., Ltd. stock?
You can buy JSS.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nxera Pharma Co., Ltd.?
The stock symbol or ticker of Nxera Pharma Co., Ltd. is JSS.F.
Which industry does the Nxera Pharma Co., Ltd. company belong to?
The Nxera Pharma Co., Ltd. industry is Biotechnology.
How many shares does Nxera Pharma Co., Ltd. have in circulation?
The max supply of Nxera Pharma Co., Ltd. shares is 91.48M.
What is Nxera Pharma Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Nxera Pharma Co., Ltd. PE Ratio is now.
What was Nxera Pharma Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Nxera Pharma Co., Ltd. EPS is -0.63 EUR over the trailing 12 months.
Which sector does the Nxera Pharma Co., Ltd. company belong to?
The Nxera Pharma Co., Ltd. sector is Healthcare.